These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 6008094)

  • 1. [A clinical evaluation of Wintomylon in the treatment of urinary infections].
    Inada T; Ebisuta K; Kitayama T; Miyakawa M
    Hinyokika Kiyo; 1966 Oct; 12(10):1150-5. PubMed ID: 6008094
    [No Abstract]   [Full Text] [Related]  

  • 2. [Drug-resistant organisms in urinary tract infections and clinical use of Wintomylon (nalidixic acid)].
    Kuze M; Kashiwagi T; Okita J; Komiya T; Nihira H
    Hinyokika Kiyo; 1966 Mar; 12(3):291-6. PubMed ID: 6006673
    [No Abstract]   [Full Text] [Related]  

  • 3. [Nalidixic acid (Wintomylon) and bacterial resistance to antibiotics in urinary tract infections].
    Makino M
    Hinyokika Kiyo; 1968 Jun; 14(6):351-6. PubMed ID: 4882490
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinical evaluation of Wintomylon (nalidixic acid) in the urinary tract infections].
    Yamasaki I; Kato T; Ogawa T
    Hinyokika Kiyo; 1965 Sep; 11(9):913-34. PubMed ID: 5324475
    [No Abstract]   [Full Text] [Related]  

  • 5. [Nalidixic acid (Neggram) in the treatment of chronic non-specific urinary tract infections].
    Porpáczy P; Haschek H; Zischka-Konorsa W; Hermanek P; Bibus B
    Wien Klin Wochenschr; 1968 Feb; 80(5):87-93. PubMed ID: 5667719
    [No Abstract]   [Full Text] [Related]  

  • 6. [Therapy results with nalidixic acid in chronic urinary tract infection].
    Broghammer H
    Arzneimittelforschung; 1968 Sep; 18(9):1139-43. PubMed ID: 4885373
    [No Abstract]   [Full Text] [Related]  

  • 7. [Clinical use of Wintomylon (nalidixic acid) in the field of urology].
    Gotoh K; Shinoda T; Ito S; Isogai K; Kimura T; Ohtani F; Ishiyama K
    Hinyokika Kiyo; 1965 Oct; 11(10):1011-4. PubMed ID: 5324357
    [No Abstract]   [Full Text] [Related]  

  • 8. [A clinical evaluation of nalidixic acid in the urinary tract infections (urinary tract infections in paraplegics. I)].
    Naito M; Kawada Y; Kondo M; Isomi A
    Hinyokika Kiyo; 1967 Jul; 13(7):561-6. PubMed ID: 5625177
    [No Abstract]   [Full Text] [Related]  

  • 9. [Clinical use of Wintomylon for urinary tract infections (mainly in spinal cord injuries)].
    Tamai T; Hashimoto H; Goto K; Imamura T; Haraguchi H
    Seikei Geka; 1967 May; 18(6):571-6. PubMed ID: 6071091
    [No Abstract]   [Full Text] [Related]  

  • 10. [Use of nalidixic acid (Wintomylon) for the treatment of urinary tract infections].
    Ohori T; Koshiba K; Goto Y; Ujiie K; Kasahara N
    Hinyokika Kiyo; 1965 Jul; 11(7):677-84. PubMed ID: 5319354
    [No Abstract]   [Full Text] [Related]  

  • 11. [The use of Wintomylon in urinary infections. Observations on 50 patients].
    Ferreira AA
    Hospital (Rio J); 1966 Nov; 70(5):1313-7. PubMed ID: 5301946
    [No Abstract]   [Full Text] [Related]  

  • 12. [Comparison of antibacterial activity of oxolinic acid (Gramurin) and nalidixic acid (Nevigramon) in vitro and in patients with urinary tract infections].
    Manitius A; Hebanowski M; Galiński J; Nowicki B
    Pol Tyg Lek; 1978 Aug; 33(34):1347-50. PubMed ID: 704439
    [No Abstract]   [Full Text] [Related]  

  • 13. [Nalidixic acid].
    Hovig B
    Tidsskr Nor Laegeforen; 1973 Oct; 93(29):2175-6. PubMed ID: 4768390
    [No Abstract]   [Full Text] [Related]  

  • 14. [Therapeutic trial with azo-Wintomylon in acute urinary infections].
    Cadena G; Garrocho C
    Prensa Med Mex; 1972; 37(5):228-31. PubMed ID: 5069461
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clinical evaluation of antimicrobial agents in urinary tract infections (urinary tract infections in paraplegics. II)].
    Kondo M
    Hinyokika Kiyo; 1967 Jul; 13(7):567-73. PubMed ID: 4868521
    [No Abstract]   [Full Text] [Related]  

  • 16. [Nalidixic acid in chronic urinary tract infections].
    Gasser G; Neuhold R
    Wien Med Wochenschr; 1967 Mar; 117(8):192-6. PubMed ID: 5589339
    [No Abstract]   [Full Text] [Related]  

  • 17. The clinical use of nalidixic acid. A review and some observations.
    Stamey TA; Nemoy NJ; Higgins M
    Invest Urol; 1969 May; 6(6):582-92. PubMed ID: 4976942
    [No Abstract]   [Full Text] [Related]  

  • 18. Sulphadimidine and nalidixic acid therapy in urinary-tract infections in general practice.
    Brown PC; Donaghy MC; Dootson PH; Titcombe DH; MacLaren DM
    Practitioner; 1971 Dec; 207(242):819-26. PubMed ID: 4947233
    [No Abstract]   [Full Text] [Related]  

  • 19. Nalidixic acid arthralgia.
    Bailey RR; Natale R; Linton AL
    Can Med Assoc J; 1972 Oct; 107(7):604 passim. PubMed ID: 4541768
    [No Abstract]   [Full Text] [Related]  

  • 20. A critical evaluation of nalidixic acid in urinary-tract infections.
    Ronald AR; Turck M; Petersdorf RG
    N Engl J Med; 1966 Nov; 275(20):1081-9. PubMed ID: 5923022
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.